Imaavy™ (nipocalimab-aahu)
for Myasthenia Gravis

Imaavy (nipocalimab-aahu) is a neonatal Fc receptor blocker used to treat generalized myasthenia gravis (gMG) in patients aged 12 and older who are AChR or MuSK antibody positive. It works by blocking the FcRn receptor, accelerating the breakdown of IgG antibodies and reducing their harmful effects on the nervous system.

Heart
Medication Guide Icon Medication Guide
Patient Website Icon Patient Website
Efficacy Data Icon Efficacy Data
New Articles Icon New Articles
Savings and Support Icon Savings and Support
Company MD Payments Icon Company MD Payments
Clinical Trials Icon Clinical Trials
Adverse Event Report Icon Adverse Event Report
Other top medicines used to treat Myasthenia Gravis - MG